Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Arthritis Rheumatol. 2019 Jun 12;71(8):1350–1359. doi: 10.1002/art.40890

Table 2:

The mRNA expression levels of selected target genes after CYR61 overexpression in dSSc dermal fibroblasts. Data are shown as fold change versus control-transfected cells (mean +/− S.D).

Gene Expression fold change vs. control vector after 48 hr transfection (n=10 patients) p-value
CYR61 213 ± 233 0.002
COL1A1 0.73 ± 0.12 0.002
ACTA2 0.75 ± 0.34 0.04
PPARG 1.34 ± 0.49 0.01
MMP1 3.70 ± 5.32 0.002
MMP3 2.40 ± 1.62 0.004
FGF2 1.42 ± 0.53 0.01
VEGF 1.45 ± 0.98 0.03